In connection with Mr. Humer’s appointment, Stephen DiPalma, the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, will cease to serve in such roles.
On April 16, 2024, Foghorn Therapeutics Inc. (the “Company”) announced that Kristian F. Humer had been appointed to serve as the Company’s Chief Financial Officer, effective immediately.
Role change
Mia L. DeMontigny
senior vice president, chief financial officer and treasurer
On April 1, 2024, William M. Schaefer was appointed as the Chief Financial Officer of Isabella Bank Corporation.
Role change
(interim)
Mark A. Skonieczny
Interim Chief Financial Officer
REV Group, Inc.
Effective
2024-04-15
Successor
Amy A. Campbell
Filed
April 15, 2024, 7:59 PM ET
Upon Ms. Campbell joining the Company on April 15, 2024, Mark A. Skonieczny, who had been serving as the Company’s Interim CFO, will step down as Interim CFO and continue in his role as President and Chief Executive Officer.
Appointed
Amy A. Campbell
Senior Vice President / Chief Financial Officer
REV Group, Inc.
Effective
2024-04-15
Filed
April 15, 2024, 7:59 PM ET
On April 15, 2024, the Board of Directors (the “Board”) of REV Group, Inc. (the “Company”) approved the appointment of Amy A. Campbell as Senior Vice President / Chief Financial Officer of the Company (“CFO”), effective as of April 15, 2024.
On April 15, 2024, the authorized members of the Board of Directors (the “Board”) of Sow Good Inc. (“Sow Good” or the “Company”) authorized and entered into an Employment Agreement dated April 15, 2024 with Brendon Fischer, the Company’s Interim Chief Financial Officer (“Employment Agreement”).
Departed
Andrew Birnbaum
Chief Executive Officer
Pedro's List, Inc.
Effective
2024-03-01
Successor
Dr. Abdul Saddiqui
Filed
April 15, 2024, 7:59 PM ET
On February 27, 2024, Mr. Andrew Birnbaum (“Mr.
Birnbaum”) informed Pedro’s List, Inc. (the “Company”) of his resignation from the positions of Chief Executive
Officer, President, Secretary, Chief Financial Officer, Treasurer, and Director of the Company effective March 1, 2024 (the “Effective
Date”).
Appointed
Dr. Abdul Saddiqui
Chief Executive Officer
Pedro's List, Inc.
Effective
2024-03-01
Filed
April 15, 2024, 7:59 PM ET
On the Effective Date, the Board has appointed Dr.
Abdul Saddiqui (“Dr. Saddiqui) , a current member the Company’s Board of Directors, as its Chief Executive Officer,
President, Chief Financial Officer, Treasurer, and Secretary and Dr. Saddiqui has agreed to such
appointments to become effective March 1, 2024 .
Appointed
Dr. Teddy Scott
President and Chief Executive Officer
Bakhu Holdings, Corp.
Effective
2024-04-10
Filed
April 15, 2024, 7:59 PM ET
On April 10, 2024, the Company appointed Dr. Teddy Scott as the President and Chief Executive Officer of the Company.
Mr. Hovsepian will succeed Jeffrey R. Tarr as principal executive officer, who will retire from the position of Chief Executive Officer effective as of April 16, 2024 (the “Transition Date”).
On April 9, 2024, the Board of Directors of Skillsoft Corp. (the “Company”) appointed Ronald W. Hovsepian as the Company’s Executive Chair and principal executive officer, effective as of April 16, 2024.
On April 11, 2024, the Board appointed Ryan Barretto, the Company’s current President, to succeed Mr. Howard as Chief Executive Officer effective as of the Effective Date.
Fu Wah resigned from his positions as the Chief Executive Officer, Chief Financial Officer, Secretary and Director of King Resources, Inc. (the “Company”).
Appointed
Wong Nga Yin Polin
Chief Executive Officer, Chief Financial Officer, Secretary and Director
Concurrently therewith, Wong Nga Yin Polin was appointed to serve as the new Chief Executive Officer, Chief Financial Officer, Secretary and Director of the Company.
On April 15, 2024, Envista Holdings Corporation (the “Company”) announced that it has appointed Paul Keel as the President and Chief Executive Officer of the Company, with such appointment to be effective as of May 1, 2024
On April 10, 2024 (the “Transition Date”), Microvast Holdings, Inc. (the “Company”) and Mr. Craig Webster, Chief Financial Officer, agreed that, effective as of the Transition Date, Mr. Webster would cease to be the Company’s Chief Financial Officer and would transition to the non-executive role of Special Advisor to the Company’s Chief Executive Officer.
On April 11, 2024, the Board of Directors, through a vote of Unanimous Written Consent appointed Mr. Ronald LoRicco, Sr, 59, to serve as the Acting Interim Chief Executive Officer.
Departed
Axel André
Executive Vice President and Chief Financial Officer
On Monday, April 8, 2024, Axel André, Executive Vice President and Chief Financial Officer of American Equity Investment Life Holding Company (the “Company”), notified the Company of his intention to resign from the Company for Good Reason pursuant to Mr. André’s Amended and Restated Change in Control Agreement with the Company, dated as of July 4, 2023, on May 10, 2024, subject to and contingent upon the consummation of the merger contemplated by the Agreement and Plan of Merger
the Board appointed Jeremy Gowler, the Company's current Chief Operating Officer and Chief Commercial Officer, as the Company's Interim Chief Executive Officer
On April 11, 2024, Sensei Biotherapeutics, Inc. (the “Company”) entered into a consulting agreement (the “Consulting Agreement”) with Erin Colgan, the Company’s former Chief Financial Officer.
Appointed
Stephen T. Wills
Chief Financial Officer
Cactus Acquisition Corp. 1 Ltd
Effective
2024-04-11
Filed
April 12, 2024, 7:59 PM ET
Stephen T. Wills was appointed to serve as the Company’s Chief Financial Officer on April 11, 2024.
Appointed
Gary Challinor
Chief Executive Officer
Cactus Acquisition Corp. 1 Ltd
Effective
2024-04-11
Filed
April 12, 2024, 7:59 PM ET
Gary Challinor was appointed to serve as the Company’s Chief Executive Officer on April 11, 2024.
On April 12, 2024, Customers Bancorp, Inc (the "Company"), the parent company of Customers Bank, promoted Philip Watkins to Chief Financial Officer of the Company.
Departed
Carla A. Leibold
Executive Vice President and Chief Financial Officer
Ms. Leibold was notified of her termination from employment with the Company on April 10, 2024, for "cause" under her employment agreement for violating Company policy, which termination was effective immediately.
Departed
Matthew Dunnigan
Chief Financial Officer
RSTRF ·
Restaurant Brands International Limited Partnership
Effective
2024-04-09
Successor
Sami Siddiqui
Filed
April 12, 2024, 7:59 PM ET
The final terms of Mr. Dunnigan’s separation from the Company and termination of his employment have been agreed as April 9, 2024.
Appointed
Sami Siddiqui
Chief Financial Officer
RSTRF ·
Restaurant Brands International Limited Partnership
Filed
April 12, 2024, 7:59 PM ET
the Board has appointed Sami Siddiqui to succeed Matthew Dunnigan as Chief Financial Officer of the Company.
On March 14, 2024, Restaurant Brands International Inc. (“ RBI ” or the “ Company ”) announced that the Board has appointed Sami Siddiqui to succeed Matthew Dunnigan as Chief Financial Officer of the Company.
Effective April 8, 2024, Carlos Rodriguez has departed the Company and will no longer serve as the Chief Financial Officer of the Company.
Appointed
Laurence E. Katz
Chief Financial Officer
MeridianLink, Inc.
Effective
2024-04-01
Filed
April 12, 2024, 7:59 PM ET
the Board had appointed Laurence E. Katz, age 54, as the Company’s Chief Financial Officer, effective upon the commencement of his employment on April 1, 2024.
James M. Till (Jim), the current Executive Vice President and Controller (Principal Accounting Officer) of Berry, providing for him to be appointed as the Executive Vice President, Chief Financial Officer & Treasurer of NewCo
On April 11, 2024, the Company’s Board of Directors appointed Brian T. Finnegan, the Company’s Senior Executive Vice President, Chief Operating Officer, to also serve as interim Chief Executive Officer and President until Mr. Taylor’s return.
On April 11, 2024, Brixmor Property Group Inc. (the “Company”) announced that James M. Taylor Jr., the Company’s Chief Executive Officer and President, is taking a temporary medical leave of absence, effective April 11, 2024.
Departed
Jeff Van Horn
Chief Financial Officer
KKR Private Equity Conglomerate LLC
Filed
April 11, 2024, 7:59 PM ET
On April 7, 2024, it was announced that Jeff Van Horn, Chief Financial Officer of KKR Private Equity Conglomerate LLC (the “Company”) and an employee of an affiliate of Kohlberg Kravis Roberts & Co. L.P. (together with its subsidiaries, “KKR”), intends to retire from KKR in the calendar year 2025.
Departed
Jeff Van Horn
Chief Financial Officer
KKR Infrastructure Conglomerate LLC
Filed
April 11, 2024, 7:59 PM ET
On April 7, 2024, it was announced that Jeff Van Horn, Chief Financial Officer of KKR Infrastructure Conglomerate LLC (the “Company”) and an employee of an affiliate of Kohlberg Kravis Roberts & Co. L.P. (together with its subsidiaries, “KKR”), intends to retire from KKR in the calendar year 2025.
Role change
David Wheeler
President, Co-Chief Executive Officer, and Chief Operating Officer
SILVER STAR PROPERTIES REIT, INC
Effective
2024-03-27
Filed
April 11, 2024, 7:59 PM ET
to continue in his current role and serve as Chief Operating Officer, which conforms his title to his actual responsibilities.
Appointed
Erik Klinger
Chief Financial Officer
Bannix Acquisition Corp.
Effective
2024-04-10
Filed
April 11, 2024, 7:59 PM ET
On April 10, 2024, Erik Klinger was appointed by Bannix Acquisition Corp. (the “Company”) to serve as the Chief Financial Officer of the Company.
Effective as of the Effective Date, the Board of Directors of the Company appointed Bryant D. Lim, the Company’s Chief Legal Officer and Corporate Secretary, as its interim Chief Financial Officer.
On April 8, 2024 (the “Effective Date”), Prelude Therapeutics Incorporated (the “Company”) and Laurent Chardonnet, the Company’s Chief Financial Officer, agreed that he will no longer serve as the Company’s Chief Financial Officer, effective as of the Effective Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.